Polynucleotides encoding coagulation factor viii
AssigneesModernaTX, Inc., Seattle Children's Hospital d/b/a Seattle Children's Research Institute
InventorsRaj Rajendran, Paolo G. V. Martini, Carol H. Miao
Life of this patent
Estimating the term…
Loading patent…
AssigneesModernaTX, Inc., Seattle Children's Hospital d/b/a Seattle Children's Research Institute
InventorsRaj Rajendran, Paolo G. V. Martini, Carol H. Miao
Estimating the term…
The invention relates to mRNA therapy for the treatment of Hemophilia A. mRNAs for use in the invention, when administered in vivo, encode Factor VIII, isoforms thereof, functional fragments thereof, and fusion proteins comprising Factor VIII. mRNAs of the invention are preferably encapsulated in lipid nanoparticles (LNPs) to effect efficient delivery to cells and/or tissues in subjects, when administered thereto. mRNA therapies of the invention increase and/or restore deficient levels of Factor VIII expression and/or activity in subjects. mRNA therapies of the invention further decrease levels of toxic metabolites associated with deficient Factor VII I activity in subjects.
-133. (canceled)
A pharmaceutical composition comprising a lipid nanoparticle, wherein the lipid nanoparticle comprises a compound having the formula (I)
Dependencies are inferred from the claim text.